Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cellectar Biosciences Inc...

    NASDAQ: CLRB · Real-Time Price · USD
    0.36
    -0.05 (-11.79%)
    At close: Jun 06, 2025, 3:59 PM
    0.36
    -1.04%
    After-hours: Jun 06, 2025, 05:58 PM EDT

    Cellectar Biosciences Statistics

    Share Statistics

    Cellectar Biosciences has 46.08M shares outstanding. The number of shares has increased by 28.54% in one year.

    Shares Outstanding

    n/a
    		 46.08M

    Shares Change (YoY)

    n/a
    		 28.54%

    Shares Change (QoQ)

    n/a
    		 11.66%

    Owned by Institutions (%)

    n/a
    		 13.92%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 4,684

    FTD / Avg. Volume

    n/a
    		 0.04%

    Short Selling Information

    The latest short interest is 2.39M, so 5.19% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.39M

    Short % of Shares Out

    n/a
    		 5.19%

    Short % of Float

    n/a
    		 5.21%

    Short Ratio (days to cover)

    n/a
    		 3.15

    Valuation Ratios

    The PE ratio is -0.25 and the forward PE ratio is -0.74. Cellectar Biosciences's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.25

    Forward PE

    n/a
    		 -0.74

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.4

    PB Ratio

    n/a
    		 0.77

    P/FCF Ratio

    n/a
    		 -0.23

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Cellectar Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.03.

    Current Ratio

    n/a
    		 2.58

    Quick Ratio

    n/a
    		 2.58

    Debt / Equity

    n/a
    		 0.03

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-4,052,858.73

    Employee Count

    n/a
    		 11

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 66K

    Effective Tax Rate

    n/a
    		 -0.15%

    Stock Price Statistics

    The stock price has increased by -86.8% in the last 52 weeks. The beta is 0.52, so Cellectar Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.52

    52-Week Price Change

    n/a
    		 -86.8%

    50-Day Moving Average

    n/a
    		 0.28

    200-Day Moving Average

    n/a
    		 0.96

    Relative Strength Index (RSI)

    n/a
    		 68.63

    Average Volume (20 Days)

    n/a
    		 10,876,484

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -51.78M

    Net Income

    n/a
    		 -44.58M

    EBITDA

    n/a
    		 -44.22M

    EBIT

    n/a
    		 -44.52M

    Earnings Per Share (EPS)

    n/a
    		 -1.22
    Full Income Statement

    Balance Sheet

    The company has 23.29M in cash and 494K in debt, giving a net cash position of 22.79M.

    Cash & Cash Equivalents

    n/a
    		 23.29M

    Total Debt

    n/a
    		 494K

    Net Cash

    n/a
    		 22.79M

    Retained Earnings

    n/a
    		 -247.34M

    Total Assets

    n/a
    		 16.04M

    Working Capital

    n/a
    		 8.87M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -47.58M and capital expenditures -104.19K, giving a free cash flow of -47.69M.

    Operating Cash Flow

    n/a
    		 -47.58M

    Capital Expenditures

    n/a
    		 -104.19K

    Free Cash Flow

    n/a
    		 -47.69M

    FCF Per Share

    n/a
    		 -1.3
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    CLRB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CLRB is $28, which is 6900% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $28

    Price Target Difference

    n/a
    		 6900%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 22, 2022. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Jul 22, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -29.95

    Piotroski F-Score

    n/a
    		 0

    Add to Watchlist